Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Astaxanthin attenuates hepatic damage and mitochondrial dysfunction in non‐alcoholic fatty liver disease by up‐regulating the FGF21/PGC‐1α pathway
Liwei Wu, Wenhui Mo, Jiao Feng, et al.
British Journal of Pharmacology (2020) Vol. 177, Iss. 16, pp. 3760-3777
Open Access | Times Cited: 106

Showing 1-25 of 106 citing articles:

Epigenetics in NAFLD/NASH: Targets and therapy
Nalini Sodum, Gautam Kumar, Sree Lalitha Bojja, et al.
Pharmacological Research (2021) Vol. 167, pp. 105484-105484
Closed Access | Times Cited: 104
Chronic Inflammation—A Link between Nonalcoholic Fatty Liver Disease (NAFLD) and Dysfunctional Adipose Tissue
Maria Denisa Petrescu, Sonia I. Vlaicu, Lorena Ciumărnean, et al.
Medicina (2022) Vol. 58, Iss. 5, pp. 641-641
Open Access | Times Cited: 82
Mitochondrial quality control in human health and disease
Bohao Liu, Chen-Zhen Xu, Yi Liu, et al.
Military Medical Research (2024) Vol. 11, Iss. 1
Open Access | Times Cited: 29
Astaxanthin ameliorates oxidative stress and neuronal apoptosis via SIRT1/NRF2/Prx2/ASK1/p38 after traumatic brain injury in mice
Xiangsheng Zhang, Yue Lu, Wen Li, et al.
British Journal of Pharmacology (2020) Vol. 178, Iss. 5, pp. 1114-1132
Open Access | Times Cited: 128
Pharmaceutical and nutraceutical potential of natural bioactive pigment: astaxanthin
Apurva D. Patil, Pramod J. Kasabe, Padma B. Dandge
Natural Products and Bioprospecting (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 68
Health benefits of astaxanthin against age-related diseases of multiple organs: A comprehensive review
Phaniendra Alugoju, V. K. D. Krishna Swamy, Naga Venkata Anusha Anthikapalli, et al.
Critical Reviews in Food Science and Nutrition (2022) Vol. 63, Iss. 31, pp. 10709-10774
Closed Access | Times Cited: 61
LncRNA-Mediated Adipogenesis in Different Adipocytes
Peiwen Zhang, Shuang Wu, Yuxu He, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 13, pp. 7488-7488
Open Access | Times Cited: 40
Bile acids-gut microbiota crosstalk contributes to the improvement of type 2 diabetes mellitus
Ruolin Gao, Xiangjing Meng, Yili Xue, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 40
Natural products in non-alcoholic fatty liver disease (NAFLD): Novel lead discovery for drug development
Lu Wang, Yonghuan Yan, Linfang Wu, et al.
Pharmacological Research (2023) Vol. 196, pp. 106925-106925
Open Access | Times Cited: 27
Carotenoids in Health as Studied by Omics-Related Endpoints
Torsten Bohn, Emilio Balbuena, Hande Z. Ulus, et al.
Advances in Nutrition (2023) Vol. 14, Iss. 6, pp. 1538-1578
Open Access | Times Cited: 23
Mini-encyclopedia of mitochondria-relevant nutraceuticals protecting health in primary and secondary care—clinically relevant 3PM innovation
Olga Golubnitschaja, Andrea Kapinová, Nafiseh Sargheini, et al.
The EPMA Journal (2024) Vol. 15, Iss. 2, pp. 163-205
Open Access | Times Cited: 13
Nutrition at the Intersection between Gut Microbiota Eubiosis and Effective Management of Type 2 Diabetes
Sevag Hamamah, Oana C. Iatcu, Mihai Covașă
Nutrients (2024) Vol. 16, Iss. 2, pp. 269-269
Open Access | Times Cited: 10
PGC-1α loss promotes mitochondrial protein lactylation in acetaminophen-induced liver injury via the LDHB-lactate axis
Weilong Hong, Xue Zeng, Houping Wang, et al.
Pharmacological Research (2024) Vol. 205, pp. 107228-107228
Open Access | Times Cited: 9
1-phenyl-3-methyl-5-pyrazolone activates the AMPK pathway to alleviate western-diet induced metabolic dysfunction-associated steatohepatitis in mice
Xiaoning Chen, Jiaofeng Huang, Yue You, et al.
Clinical Nutrition (2025) Vol. 45, pp. 136-147
Closed Access | Times Cited: 1
Cordycepin alleviates metabolic dysfunction-associated liver disease by restoring mitochondrial homeostasis and reducing oxidative stress via Parkin-mediated mitophagy
Haiying Tian, Daojiang Yu, Teng Xie, et al.
Biochemical Pharmacology (2025) Vol. 232, pp. 116750-116750
Open Access | Times Cited: 1
Activating Adenosine Monophosphate–Activated Protein Kinase Mediates Fibroblast Growth Factor 1 Protection From Nonalcoholic Fatty Liver Disease in Mice
Qian Lin, Zhifeng Huang, Genxiang Cai, et al.
Hepatology (2020) Vol. 73, Iss. 6, pp. 2206-2222
Open Access | Times Cited: 65
The Gut Microbiome and Ferroptosis in MAFLD
Jie Ji, Liwei Wu, Jue Wei, et al.
Journal of Clinical and Translational Hepatology (2022) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 34
Terpenoids: Natural Compounds for Non-Alcoholic Fatty Liver Disease (NAFLD) Therapy
Pengyu Yao, Yajuan Liu
Molecules (2022) Vol. 28, Iss. 1, pp. 272-272
Open Access | Times Cited: 30
Phytochemicals from the Cocoa Shell Modulate Mitochondrial Function, Lipid and Glucose Metabolism in Hepatocytes via Activation of FGF21/ERK, AKT, and mTOR Pathways
Miguel Rebollo‐Hernanz, Yolanda Aguilera, Maria A. Martín‐Cabrejas, et al.
Antioxidants (2022) Vol. 11, Iss. 1, pp. 136-136
Open Access | Times Cited: 29
Structural elucidation and anti-nonalcoholic fatty liver disease activity of Polygonatum cyrtonema Hua polysaccharide
Wei Liu, Taili Shao, Lei Tian, et al.
Food & Function (2022) Vol. 13, Iss. 24, pp. 12883-12895
Closed Access | Times Cited: 28
Type 2 Diabetes Mellitus, Non-Alcoholic Fatty Liver Disease, and Metabolic Repercussions: The Vicious Cycle and Its Interplay with Inflammation
Rafał Frankowski, Mateusz Kobierecki, Andrzej Wittczak, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9677-9677
Open Access | Times Cited: 21
Mitochondrial Dysfunction in Metabolic Dysfunction Fatty Liver Disease (MAFLD)
Ying Zhao, Yanni Zhou, Dan Wang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17514-17514
Open Access | Times Cited: 21
Mitochondrial Modulators: The Defender
Emmanuel Ayobami Makinde, Linlin Ma, George D. Mellick, et al.
Biomolecules (2023) Vol. 13, Iss. 2, pp. 226-226
Open Access | Times Cited: 17
Fibroblast growth factor 21 in metabolic syndrome
Ming Yang, Chongbin Liu, Na Jiang, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top